Sort   by:  
 Page size 
UnknownBosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.
Not available
S-EPMC4979199 | biostudies-literature
UnknownBosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Not available
S-EPMC5966023 | biostudies-literature
UnknownNon-radiation risk factors for leukemia: A case-control study among chornobyl cleanup workers in Ukraine.
Not available
S-EPMC4609257 | biostudies-literature
UnknownHigh-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.
Not available
S-EPMC2878787 | biostudies-literature
UnknownHigh-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial.
Not available
S-EPMC3487557 | biostudies-literature
UnknownGenomic characterization of chronic lymphocytic leukemia (CLL) in radiation-exposed Chornobyl cleanup workers.
Not available
S-EPMC5930419 | biostudies-literature
Sort   by:  
 Page size